https://www.scmp.com/rss/505487/feed Andrew McLachlan receives research funding from the NHMRC, research scholarship funding from GSK for a PhD student under his supervision and has previously received (and disclosed) in kind research support from Pfizer and GSK for investigator initiated research projects. Andrew serves and is paid as an expert on Australian government committees related to medicines regulation and anti-doping. en https://assets.i-scmp.com/static/img/icons/scmp-meta-1200x630.png https://www.scmp.com Researchers testing the head lice drug Ivermectin as a possible treatment for Covid-19 have seen promising results in laboratory studies. But the research is in its early stages and the drug is yet to be tested on people with Covid-19. There’s so much we don’t know, including the right dose and delivery method for people with coronavirus infection. So if you’re thinking of buying some just in case, think again. What is Ivermectin currently used for? Ivermectin is an antiparasitic agent that was... https://www.scmp.com/week-asia/explained/article/3078922/could-head-lice-drug-hold-key-treating-coronavirus?utm_source=rss_feed https://www.scmp.com/week-asia/explained/article/3078922/could-head-lice-drug-hold-key-treating-coronavirus?utm_source=rss_feed Wed, 08 Apr 2020 04:00:22 +0000